Home — Health The controversial approval of an Alzheimer’s drug reignites the battle over the underlying cause of the disease

The controversial approval of an Alzheimer’s drug reignites the battle over the underlying cause of the disease

by Mary Sewell

I am a happy guy, but hearing that the FDA had approved Aduhelm and that I am eligible for the treatment, I am living happier, of course,” Archambault said immediately before getting the infusion at Butler Hospital in Providence R.I. “The thought that the last stage [of Alzheimer’s] may now be far away for me, or even that I might stay as I am is incredible.” His biggest hope, he said, is that his three children would not have to worry about him.

J3LZ55GO5YI6XIREXVM32IQZPQ

You may also like

Leave a Comment